 |
|
| 100% Natural source Vitamin E with Alpha Lipoic Acid and Vitamin C formulated in Bio-Sol base to enhance its absorption. |
| |
| USAGE |
|
Natopherol ALA Plus is a combination of antioxidants consisting of natural source of Vitamin E,
d-alpha-tocopherol, Alpha Lipoic Acid (ALA) and Vitamin C. This antioxidant Defense System helps protect the body from
the damage of free radicals by neutralizing them so you stay healthy |
| |
| FEATURES |
 |
Vitamin E acts as the 1st line of defense against free radical attack
|
|
Alpha Lipoic Acid (ALA) rejuvenates the antioxidant network to extend the antioxidant power |
|
Vitamin C regenerates Vitamin E to boost antioxidant level |
|
Formulated using Bio-Sol dissolution system that enables the antioxidants
to be absorbed more efficiently by the body. |
|
Can be taken any time of the day, regardless of meals
|
| |
| Click here for more Nutritional Information |
|
|
| NUTRITIONAL FACTS |
| |
|
ALA is the universal antioxidant. |
|
It can recycle all network antioxidants (e.g.: vitamin C, glutathione, coenzyme Q10 and vitamin E) and restore its antioxidants power. |
|
Diabetes is shown to increase the production of free radicals in the body, resulting in oxidative stress which causes diabetes complications. |
|
ALA helps to improve diabetes complication by increasing insulin sensitivity, relieving neuropathic symptoms and also improving function of the heart.1,2,3 |
| |
| References |
| 1. |
Jacob S et al 1999. Oral administration of RAC lipoic acid modulates insulin sensitivity in patient with type 2 diabetes mellitus: a placebo-controlled pilot trial. Free Radical Biology & Medicine, 27: 309-314.
|
| 2. |
Ziegler D et al. 2006. Oral treatment with alpha lipoic acid improves symptomatic diabetic polyneuropathy. Diabetic Care, 29(11): 2365-70.
|
| 3. |
Sola S et al. 2005. Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic synfromeL results of irbesartan and lipoic acid in endothelial dysfunction (ISLAND) study. J of Am Heart Ass., 111:343-8.
|
| |
|
